Company page

Avalyn Pharma Inc.

Avalyn Pharma Inc. is a public company trading under the ticker AVLN in the American market. With a market capitalization of approximately $1.39 billion, the company focuses on developing innovative therapies for patients with serious diseases. Avalyn Pharma aims to advance its pipeline and contribute to the healthcare sector through its research and development efforts.